Company Search:
Advanced Search
Sponsored Links
Regeneus Ltd Company Snapshot
Regeneus Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Regeneus Ltd with three other pharmaceutical manufacturers in Australasia: ECS Botanics Holdings Ltd (2019 sales of 1,384.00 Australian Dollars [US$949.89 ] ), Genetic Technologies Limited (25,444.00 Australian Dollars [US$17,463.23 ] of which 100% was Operations), and Prescient Therapeutics Ltd (72,109.00 Australian Dollars [US$49,491.29 ] ).

Sales Analysis. Sales fell dramatically in 2019: Regeneus Ltd reported sales of A$25,077.00 (US$17.21 thousand) for the fiscal year ending June of 2019. This represents a sharp decrease of 95.9% versus 2018, when the company's sales were A$610,511.00 .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Regeneus Ltd
  Stock Performance Chart for Regeneus Ltd
  Stock Data: Recent Stock Performance:
  Current Price (11/7/2019): .08
(Figures in Australian Dollars)
1 Week 9.3%   13 Weeks 9.3%  
4 Weeks -4.7%   52 Weeks -58.1%  
Regeneus Ltd Key Data:
  Ticker: RGS Country: Australia
  Exchanges: Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 25,077
(Year Ending Jan 2020).
Employees: N/A
  Currency: Australian Dollars Market Cap: 17,524,639
  Fiscal Yr Ends: June Shares Outstanding: 213,715,104
  Share Type: Ordinary Closely Held Shares: 65,478,188
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.